Patents by Inventor Suthar Sharad KUMAR

Suthar Sharad KUMAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
    Patent number: 11845758
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Grant
    Filed: June 30, 2023
    Date of Patent: December 19, 2023
    Assignees: PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT., EÖTVÖS LORÁND TUDOMÁNYEGYETEM
    Inventors: András Málnási-Csizmadia, Máté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajik Horváth, József Répási
  • PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
    Publication number: 20230339959
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Application
    Filed: June 30, 2023
    Publication date: October 26, 2023
    Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajik HORVÁTH, József RÉPÁSI
  • Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms
    Patent number: 11746112
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: September 5, 2023
    Assignees: EÖTVÖS LORÁND TUDOMÁNYEGYETEM, PRINTNET KERESKEDELMI ÉS SZOLGÁLTATÓ KFT.
    Inventors: András Málnási-Csizmadia, Maté Gyimesi, András Szabó, Péter Hári, Suthar Sharad Kumar, Mihály Kovács, Ádám István Horváth, Máté Pénzes, István Lörincz, László Végner, Zoltán Simon, Sándor Bátori, Zoltán Szönyegi, Vajk Horváth, József Répási
  • PHARMACEUTICALLY EFFECTIVE COMPOUNDS INHIBITING SELECTIVELY THE MYOSIN 2 ISOFORMS
    Publication number: 20210087201
    Abstract: The present invention relates to compounds of formula (I) or (II) pharmaceutically acceptable salts, solvates, tautomers, stereoisomers thereof, including enantiomers, diastereomers, racemic mixtures, mixtures of enantiomers, or combinations thereof, and pharmaceutical uses of the compounds.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 25, 2021
    Inventors: András MÁLNÁSI-CSIZMADIA, Máté GYIMESI, András SZABÓ, Péter HÁRI, Suthar Sharad KUMAR, Mihály KOVÁCS, Ádám István HORVÁTH, Máté PÉNZES, István LORINCZ, László VÉGNER, Zoltán SIMON, Sándor BÁTORI, Zoltán SZONYEGI, Vajk HORVÁTH, József RÉPÁSI